Epicentre (an Illumina company)
Contact Us: 800-284-8474           Log In
 

Epicentre Forum 1 (4)

AmpliScribe T7, SP6, and T3 Transcription Kits are designed for high yield in vitro synthesis of RNA ranging in size from as small as 25 nucleotides to multi-kilobases. The unique enzyme formulations in the AmpliScribe Kits enable researchers to obtain RNA yields 10-30 times higher than those possible with conventional transcription kits. In addition, AmpliScribe kits can be used to generate capped transcripts. Answers to some of the questions that Epicentre's Technical Services Department has received concerning AmpliScribe Transcription Kits are given below. If you have any other questions related to AmpliScribe Kits or other products, please contact Epicentre's Technical Services.

I want to synthesize 5 different RNAs, ranging in size from 150 bases to 8 kilobases. What yields can I expect?

Transcripts throughout this size range can be produced using an AmpliScribe Transcription Kit. As a benchmark, the AmpliScribe T7 Control Template yields about 150 µg of a 1.4 kb RNA transcript in a 20 µl AmpliScribe reaction in 2 hr, or about 900 molecules of RNA per molecule of DNA template. The yield from other templates will vary somewhat, depending on the DNA sequence and the size of the RNA it encodes. Because initiation is the rate-limiting step in most transcription reactions, highest mass (µg) yields per reaction are obtained using templates encoding larger transcripts. Smaller transcripts will result in lower mass, but higher molar yields. For example, yields of 45-60 µg of a 63-base active ribozyme were obtained per 20 µl reaction in 2 hr using an AmpliScribe T7 Kit;1 thus, greater than 18,500 RNA molecules were obtained per template molecule in these transcription reactions.

What yields can I expect for capped transcripts?

For synthesis of capped RNA using a cap analog, the concentration of GTP is reduced compared to standard AmpliScribe reactions in order to favor incorporation of the cap analog. Thus, the yield of RNA from these reactions will be lower than that from standard reactions. Still, higher yields of capped transcripts will be obtained using AmpliScribe Kits than using conventional kits. For example, we have observed yields of 30 µg to 60 µg per 20 µl reaction, with approximately 50% capping, when transcribing the AmpliScribe T7 Control Template. Of course, yields will vary depending on the template.

What can I do to assure that a single full-length transcript is obtained?

Prior to the transcription reaction, the template should be linearized using a restriction enzyme that generates a 5´-overhang or a blunt end. 3´-overhangs generated by enzymes like Pst I can serve as false transcription start sites, resulting in spurious products.2 Also, carefully check that the restriction enzyme digestion of the template has gone to completion. Incomplete digestion may result in "run-on" transcription because the RNA polymerase will transcribe continuously around a circular plasmid template.

I would like to generate transcripts from a small oligonucleotide carrying the T7 promoter rather than from a plasmid. Is this possible?

Yes, transcription from oligonucleotides carrying a phage promoter is possible, but yields may be reduced relative to yields from plasmid templates. Ideally, such templates should be completely double-stranded molecules. Although transcription is possible from oligonucleotide templates in which only the promoter portion is double-stranded,3 the single-stranded regions of the template, as well as other single-stranded DNA in a reaction mixture may be transcribed in a promoter-independent fashion, resulting in non-specific transcripts. Therefore, we recommend using only completely double-stranded templates for most applications.

I am synthesizing a very small RNA, and obtaining products that differ in size by a few bases from my expected product. What could be happening?

There is often heterogeneity in both the initiation, and termination of transcription when using phage polymerases. For example, researchers working with SP6 RNA polymerase have observed termination of transcription at both the last and penultimate nucleotides of the transcription template, as well as the addition of a 3´-terminal non-encoded nucleotide.4 Others have observed heterogeneity in the location of the start of transcription with T7 RNA polymerase, with "start sites" in each of the final three bases of the promoter.5

Although variability in transcript size due to imprecise initiation and termination may occur for RNA of any size, size variability is more obvious for small transcripts. Researchers synthesizing small RNAs may notice a family of products differing in size by a few bases after gel analysis of transcripts. However, even with this variability, the majority of the transcripts will have the expected 5´- and 3´- sequences, and the minority that have variable ends will likely be biologically active.

Can reactions using AmpliScribe Kits be modified to improve yields?

Epicentre's scientists have optimized variables for in vitro transcription using AmpliScribe Kits with typical templates to the point that it is difficult to improve yields. For example, 75% of all of the NTPs in a standard 20 µl reaction mixture are incorporated into RNA in 2 hr using the Control Template provided with the AmpliScribe T7 Transcription Kit. Even higher yields can be obtained by lengthening the reaction time to 3 hr. Reactions longer than 3 hr are not recommended, as they could result in RNA degradation. When synthesizing small (less than 300 bases), or difficult-to-transcribe templates, yields may be improved by raising the temperature of the reaction to 42°C.

What methods do you recommend for isolating my RNA after transcription?

The AmpliScribe reaction contains large amounts of NTPs, salts, and protein that may need to be removed before further manipulation of the RNA. Although organic extraction and ethanol precipitation may be used for RNA purification, we generally recommend an ammonium acetate precipitation procedure6 for transcripts longer than 100 bases. This procedure results in selective precipitation of the RNA to remove DNA, NTPs, and protein. Virtually 100% of the RNA is recovered, and it is both pure and biologically active. The ammonium acetate precipitation procedure is simple and eliminates the need for both DNase I treatment and organic extraction. However, since ammonium ions strongly inhibit T4 polynucleotide kinase, care should be taken to remove all of the salt from the RNA prior to end-labeling or similar reactions.

Can AmpliScribe Kits be used to synthesize high specific activity radiolabeled RNA?

AmpliScribe Kits are optimized for the production of large amounts of non-radioactive RNA, and generally are not recommended for synthesis of radioactive RNA. Because of the high concentration of NTPs used in our standard protocol, it is difficult to add enough of a radioactive NTP to synthesize radiolabeled RNA of high specific activity. Although, with a modified protocol, some of our customers have synthesized extremely high specific activity RNA (in much lower yields than would be obtained in a standard AmpliScribe reaction). Epicentre's T7, SP6, and T3 RiboScribe™ Kits are preferable for synthesis of radiolabeled RNA probes.

Can I substitute a high concentration of phage RNA polymerase for the AmpliScribe enzyme solution in an AmpliScribe reaction?

No. The AmpliScribe enzyme mix is specially formulated to allow yields that are not possible with even the highest concentration of the corresponding phage RNA polymerase.

References

  1. Hoffman and Johnson (1994) BioTechniques 17, 372.
  2. Schenbom and Mierendorf, (1985) Nucleic Acids Res. 13, 6223.
  3. Milligan et al. (1987) Nucleic Acids Res. 15, 8783.
  4. Nielson and Shapiro (1986) Nucleic Acids Res. 14, 5936.
  5. Melton et al. (1984) Nucleic Acids Res. 12, 7035.
  6. Epicentre Forum (1994) 1(2), 8.

HOME | PRODUCTS | WHAT'S NEW | TECHNICAL RESOURCES | ORDERING | COMPANY

Epicentre on Facebook  Epicentre on Twitter  Epicentre's Technical Blog   Epicentre® (an Illumina® company)
©2012 Epicentre. All Rights Reserved.